Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:13 pm Sale | 2025-09-30 | 13G | GH Research PLC GHRS | Terwey Theis H | 1,784,266 2.900% | -2,908,637 (-61.98%) | Filing History |
| 2025-11-14 2:01 pm Purchase | 2025-09-30 | 13G | GH Research PLC GHRS | Lynx1 Capital Management LP | 8,601,189 13.900% | 2,248,120 (+35.39%) | Filing History |
| 2025-08-14 6:01 pm Purchase | 2025-06-30 | 13G | GH Research PLC GHRS | RA CAPITAL MANAGEMENT L.P. | 7,676,697 12.400% | 732,049 (+10.54%) | Filing History |
| 2025-08-14 07:19 am Sale | 2025-06-30 | 13G | GH Research PLC GHRS | Terwey Theis H | 4,692,903 7.600% | -1,495,167 (-24.16%) | Filing History |
| 2025-08-06 12:01 pm Purchase | 2025-06-30 | 13G | GH Research PLC GHRS | FMR LLC | 5,092,145 8.200% | 842,565 (+19.83%) | Filing History |
| 2025-05-15 4:58 pm Purchase | 2025-03-31 | 13G | GH Research PLC GHRS | RA CAPITAL MANAGEMENT L.P. | 6,944,648 11.200% | 257,959 (+3.86%) | Filing History |
| 2025-05-15 4:31 pm Sale | 2025-03-31 | 13G | GH Research PLC GHRS | BIOTECHNOLOGY VALUE FUND L P | 8,827,712 14.200% | -1,572,446 (-15.12%) | Filing History |
| 2025-05-15 08:26 am Purchase | 2025-03-31 | 13G | GH Research PLC GHRS | RTW Investments, LP | 5,499,769 8.900% | 2,172,640 (+65.30%) | Filing History |
| 2025-05-12 10:32 am Purchase | 2025-03-31 | 13G | GH Research PLC GHRS | FMR LLC | 4,249,580 6.900% | 1,762,210 (+70.85%) | Filing History |
| 2025-02-12 09:19 am Sale | 2024-12-31 | 13G | GH Research PLC GHRS | FMR LLC | 2,487,370 4.800% | -649,499 (-20.71%) | Filing History |
| 2025-02-10 5:29 pm Purchase | 2025-02-06 | 13G | GH Research PLC GHRS | Lynx1 Capital Management LP | 6,353,069 10.200% | 1,494,075 (+30.75%) | Filing History |
| 2025-02-10 5:22 pm Purchase | 2024-12-31 | 13G | GH Research PLC GHRS | Lynx1 Capital Management LP | 4,858,994 9.300% | 663,100 (+15.80%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | GH Research PLC GHRS | RA CAPITAL MANAGEMENT L.P. | 6,686,689 12.900% | 1,099,356 (+19.68%) | Filing History |
| 2024-11-14 09:05 am Purchase | 2024-09-30 | 13G | GH Research PLC GHRS | Lynx1 Capital Management LP | 4,195,894 8.100% | 1,201,835 (+40.14%) | Filing History |
| 2024-02-16 4:57 pm Purchase | 2024-02-06 | 13G | GH Research PLC GHRS | Lynx1 Capital Management LP | 2,994,059 5.800% | 2,994,059 (New Position) | Filing History |
| 2024-02-14 8:34 pm Sale | 2023-12-31 | 13G | GH Research PLC GHRS | Venrock Healthcare Capital Partners II, L.P. | 1,318,327 2.500% | -2,198,798 (-62.52%) | Filing History |
| 2024-02-14 5:01 pm Purchase | 2023-12-31 | 13G | GH Research PLC GHRS | RA CAPITAL MANAGEMENT L.P. | 5,587,333 10.700% | 26,215 (+0.47%) | Filing History |
| 2024-02-14 09:54 am Purchase | 2023-12-31 | 13G | GH Research PLC GHRS | BIOTECHNOLOGY VALUE FUND L P | 10,400,158 19.990% | 1,125,000 (+12.13%) | Filing History |
| 2024-02-14 07:04 am Purchase | 2023-12-31 | 13G | GH Research PLC GHRS | RTW Investments, LP | 3,327,129 6.400% | 3,327,129 (New Position) | Filing History |
| 2024-02-09 09:03 am Sale | 2024-02-08 | 13G | GH Research PLC GHRS | FMR LLC | 3,136,869 6.030% | -1,319,112 (-29.60%) | Filing History |